Researcher Varun Warrier said the findings could potentially lead “to better treatment and support” for people with a host of psychiatric and neurological conditions.
Category: Breaking
Major Insurer Blue Shield Of California Drops CVS For Amazon, Cuban’s Cost Plus Drugs In Cost-Cutting Move
Cost Plus Drug Company, Abarca and Amazon Pharmacy will replace a majority of the services currently provided by CVS Caremark.
Cancer Rates Among Americans Under 50 Are Slightly Rising, New Study Finds
Though cancer rates in Americans 50 years and older are declining, researchers found rates in Americans under 50 are on the rise, with adults between 30 and 39 seeing the biggest increase.
What To Know About The Potential Health Risks Of The Maui Fires—From Birth Defects To Cancer
The fires have already killed 99 people as of Monday, making it one of the deadliest fires in American history.
What To Know About Gastroparesis: Lawsuit Claims Ozempic And Mounjaro Causes The Severe Stomach Disorder
The lawsuit alleges that the drugs not only cause gastroparesis, but that both manufacturers knew it was a side effect but didn’t disclose it to consumers.
What We Know About ‘Eris’ Covid Variant EG.5: The Dominant Stain Driving An Uptick In Cases
“Eris” makes up 17% of all cases in the U.S., but its symptoms aren’t believed to be more severe than earlier variants.
Suicide Rate Reaches All-Time High In 2022, CDC Data Suggests
Death by suicide in the U.S. increased by 2.6% between 2021 and 2022, according to provisional data from the CDC.
Kim Kardashian Promotes $2,500 Body Scan—Here’s What To Know And Why Some Experts Warn Against It
Some experts caution against the scans—brought into the mainstream by celebrities like Kardashian—as they say it’s a waste of healthcare resources and money.
Cat Coronavirus Outbreak: Thousands Of Felines Die In Cyprus As Vets Turn To Human Drug For Treatment
An animal activist group estimates the virus has killed some 300,000 cats since January.
Wegovy Shortage: Supplies Of Weight-Loss Drug Remain Restricted Amid Booming Sales
Novo Nordisk, which also sells diabetes drug Ozempic, said it is working to build capacity but expects periodic supply constraints for the near future.
